Found: 22
Select item for more details and to access through your institution.
Prognostic factors affecting the risk of thoracic progression in extensive-stage small cell lung cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Phase II study of Amrubicin monotherapy in elderly or poor-risk patients with extensive disease of small cell lung cancer.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 5, p. 642, doi. 10.1007/s10637-017-0482-8
- By:
- Publication type:
- Article
Phase I study of Nedaplatin, a platinum based antineoplastic drug, combined with nab-paclitaxel in patients with advanced squamous non–small cell lung cancer.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 1, p. 45, doi. 10.1007/s10637-017-0472-x
- By:
- Publication type:
- Article
Activity of Nivolumab and Utility of Neutrophil-to-Lymphocyte Ratio as a Predictive Biomarker for Advanced Non-Small-Cell Lung Cancer: A Prospective Observational Study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Evaluation of Amrubicin as a Third or Later Line of Chemotherapy for Advanced Non-Small Cell Lung Cancer.
- Published in:
- Chemotherapy (0009-3157), 2013, v. 59, n. 2, p. 99, doi. 10.1159/000354207
- By:
- Publication type:
- Article
Interstitial pneumonia following administration of pegfilgrastim during carboplatin and etoposide chemotherapy for small-cell lung cancer.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Prognostic significance of galectin‐3 expression in patients with resected NSCLC treated with platinum‐based adjuvant chemotherapy.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 10, p. 1570, doi. 10.1111/1759-7714.13945
- By:
- Publication type:
- Article
Current status and progress of concurrent chemoradiotherapy in patients with locally advanced non‐small cell lung cancer prior to the approval of durvalumab.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 4, p. 1005, doi. 10.1111/1759-7714.13357
- By:
- Publication type:
- Article
Prognostic significance of IMMT expression in surgically‐resected lung adenocarcinoma.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 11, p. 2142, doi. 10.1111/1759-7714.13200
- By:
- Publication type:
- Article
Evaluation of osimertinib efficacy according to body surface area and body mass index in patients with non‐small cell lung cancer harboring an EGFR mutation: A prospective observational study.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 4, p. 880, doi. 10.1111/1759-7714.13018
- By:
- Publication type:
- Article
Questionnaire survey on patient awareness of invasive rebiopsy in advanced non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 3, p. 501, doi. 10.1111/1759-7714.12964
- By:
- Publication type:
- Article
Amrubicin monotherapy for elderly patients with relapsed extensive‐disease small‐cell lung cancer: A retrospective study.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 10, p. 1279, doi. 10.1111/1759-7714.12833
- By:
- Publication type:
- Article
Efficacy and risk of cytotoxic chemotherapy in extensive disease-small cell lung cancer patients with interstitial pneumonia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Evaluation of gefitinib efficacy according to body surface area in patients with non-small cell lung cancer harboring an EGFR mutation.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 5, p. 939, doi. 10.1007/s00280-014-2570-1
- By:
- Publication type:
- Article
Impact of EGFR genotype on the efficacy of osimertinib in EGFR tyrosine kinase inhibitor-resistant patients with non-small cell lung cancer: a prospective observational study.
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 4883, doi. 10.2147/CMAR.S207170
- By:
- Publication type:
- Article
Prognostic significance of the 8th edition of the TNM classification for patients with extensive disease small cell lung cancer.
- Published in:
- Cancer Management & Research, 2018, v. 10, p. 6039, doi. 10.2147/CMAR.S181789
- By:
- Publication type:
- Article
Impact of PD-L1 Expression in Patients with Surgically Resected Non-Small-Cell Lung Cancer.
- Published in:
- Oncology, 2017, v. 92, n. 5, p. 283, doi. 10.1159/000458412
- By:
- Publication type:
- Article
Comparison of the Efficacy of Gefitinib in Patients with Non-Small Cell Lung Cancer according to the Type of Epidermal Growth Factor Receptor Mutation.
- Published in:
- Oncology, 2014, v. 87, n. 4, p. 215, doi. 10.1159/000362603
- By:
- Publication type:
- Article
Evaluation of concurrent chemoradiotherapy for locally advanced NSCLC according to EGFR mutation status.
- Published in:
- Oncology Letters, 2017, v. 14, n. 1, p. 885, doi. 10.3892/ol.2017.6231
- By:
- Publication type:
- Article
Successful chemotherapy with carboplatin and nab-paclitaxel for thymic large cell neuroendocrine carcinoma: A case report.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Prognostic differences between oligometastatic and polymetastatic extensive disease-small cell lung cancer.
- Published in:
- PLoS ONE, 2019, v. 14, n. 5, p. 1, doi. 10.1371/journal.pone.0214599
- By:
- Publication type:
- Article
Prognostic significance of nestin expression in patients with resected non-small cell lung cancer treated with platinum-based adjuvant chemotherapy; relationship between nestin expression and epithelial to mesenchymal transition related markers.
- Published in:
- PLoS ONE, 2017, v. 12, n. 3, p. 1, doi. 10.1371/journal.pone.0173886
- By:
- Publication type:
- Article